AQW 30159/17-22 Written question to the Minister of Health
To ask the Minister of Health to detail the comparison between the funding required for anti-viral treatments for COVID-19 and the funding required for support in hospital short of mechanical ventilation.
Asked by Paula Bradshaw MLA on 23 February 2022
- Answered
- Written
- After due date
- Tabled
- 23 February 2022
- Answer due by
- 10 March 2022
- Answered
- 25 March 202230 days after tabling
- Department
- Department of Health
- Priority question
- No
Answer
COVID-19 antivirals and monoclonal antibody treatments (nMAbs) are currently funded by the Department of Health and Social Care (DHSC) through central procurement on behalf of the four UK countries. Therefore cost detail is unavailable and a financial comparison cannot be determined due to insufficient data and/or evidence.